EBEric Baetscher

Eric Baetscher

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Eric Baetscher has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Escalation of Ethanol Drinking in Mice Is Associated With Neurochemical Changes in the Dorsal Striatum

    by Eric Baetscher, Timothy L. Carlson, Connor Hilts, Jade L. Thomas, Patrick N. Reardon, Verginia C. Cuzon Carlson, Christopher D. Kroenke

    Prior studies indicate that a bias towards excitation in the excitatory/inhibitory balance occurs in the dorsal striatum as a result of chronic heavy alcohol use. However, investigations of the dorsal striatum by noninvasive means, such as magnetic resonance spectroscopy (MRS) in vivo, have been lacking. In this study, 49 mice (27 female) on a C57BL/6J genetic background were subject to a chronic intermittent ethanol and forced swim stress (CIE‐FSS) procedure. For each mouse, MRS data were acquired at two timepoints from a single voxel covering the dorsal striatum bilaterally. The baseline MRS timepoint occurred in an ethanol naïve state. Ethanol drinking for all mice consisted of 1‐h/day access to one bottle of 15% ethanol, for 5 days/week. After a 6‐week ethanol drinking acclimation period, mice were assigned to four experimental groups: air and no stress, air and stress, EtOH vapour and no stress, and EtOH vapour and stress. Mice then underwent four cycles of CIE‐FSS, each cycle consisted of 1 week of vapour (air or ethanol) followed by 1 week of either 10 min of FSS swim stress or no swim stress, and 1‐h access to 15% ethanol. A follow‐up MRS timepoint occurred at the conclusion of the 14‐week CIE‐FSS protocol, after at least 43 h of abstinence from ethanol. Whole‐cohort ethanol drinking increased from a mean ± SEM of 1.51 ± 0.11 g/kg at Week 1, to a mean of 3.15 ± 0.13 g/kg at Week 14. Robust increases in several neurochemicals were observed between baseline and follow up, with the largest increases found for glutamate, glutamine, taurine, and creatine. Two sets of analysis on MRS data were performed: (1) assessing effects of experimental group (CIE, FSS and/or sex) on striatal neurochemistry and (2) investigating correlations between longitudinal changes in ethanol drinking and changes in neurochemical concentrations. Striatal neurochemical concentrations exhibited CIE‐FSS group effects (1), notably EtOH vapour exposure significantly reduced lactate concentrations at follow up. The change in glutamate between baseline and follow up was significantly lower in EtOH vapour exposed mice. Changes in the glutamate/glutamine ratio were markedly reduced in the EtOH vapour condition. In our correlational analysis (2) of changes in drinking versus changes in neurochemical concentrations from baseline to follow up, we found that female mice have strong positive linear correlations between the change in ethanol drinking and the changes in concentration of glutamate, glutamine, taurine, myo‐inositol and creatine. In male mice, inverse correlations were found between changes in drinking and changes in glutamate, taurine and creatine concentrations. Additionally, the change in cerebral ventricle volume was found to correlate with the change in ethanol drinking, but ventricular volume change was not significantly affected by CIE or FSS. Together, the observed effects of CIE on MRS outcomes in dorsal striatum and the correlations between neurochemical changes and drinking behaviour substantiate the importance of the dorsal striatum in escalating ethanol consumption and are promising evidence for the utility of MRS to detect behaviourally relevant changes in heavy ethanol drinking phenotypes.


  • Open Access

    Annual 12‐Week Dosing Gap of Natalizumab: Clinical Efficacy, Blood Biomarkers, and CSF Cell Composition

    by Regina Berkovich, Tilman Schneider‐Hohendorf, Eric Baetscher, Evan L. Riddle, Marie Deffner, Emily Katsnelson, Janine Ferrant‐Orgettas, Julie Czerkowicz, John Anderson, Susan E. Goelz, et al.

    Objective: Natalizumab (NTZ) is a highly effective therapy for multiple sclerosis (MS); however, its use is limited by the risk of a rare potentially severe opportunistic brain infection, progressive multifocal leukoencephalopathy (PML). Alternative dosing strategies are evaluated to reduce PML risk while still maintaining efficacy, which include extending the dosing interval (EID) or a lesser‐known annual dosing gap (aGAP), which is the focus of this prospective observational single‐site cohort study. We evaluated whether aGAP affects the efficacy of NTZ, which biomarkers could be useful for a personalized dosing strategy, and potential cellular mechanisms that might contribute to reducing the risk of PML during aGAP. Methods: Clinical assessments, quantifications of NTZ, neurofilament light chain (NfL), and soluble vascular cell adhesion molecule‐1 (sVCAM‐1) were performed for ten study participants of a clinical trial (NCT04048577); CSF single‐cell RNA‐sequencing data from nine participants (15 samples) were analyzed together with 48 healthy and 35 MS controls. Results: Although NTZ serum levels were decreased below EID levels and sVCAM‐1 levels were increased, aGAP was not associated with MS activity as measured by EDSS and MRI. After aGAP, while CSF cell counts remained stable, the CSF immune cell composition changed and NfL values were increased 3 months post gap. CSF proportions of CD4, CD8, and natural killer cell subsets increased towards levels of untreated MS patients, while B‐cell proportions remained unchanged. Interpretation: The differential CSF composition associated with sVCAM‐1 serum level changes suggests that selective immune cell trafficking may occur during aGAP, potentially contributing to PML prevention.


  • Open Access

    Pregnancy and weaning regulate human maternal liver size and function

    by Alexandra Q. Bartlett, Kimberly K. Vesco, Jonathan Q. Purnell, Melanie Francisco, Erica Goddard, Xiangnan Guan, Andrea DeBarber, Michael C. Leo, Eric Baetscher, William Rooney, et al.

    Significance: These human data are consistent with reproductive control of liver size and function in women and concur with recent observations in rodents, suggesting a conserved liver biology. The question of whether this described liver biology has implications for maternal health during pregnancy or sex-specific risk for liver disease remains to be determined. However, our evidence suggestive of weaning-induced liver involution in women may lead to improved understanding of the high rates of liver metastasis observed in young postpartum breast cancer patients.